AMI Investment Management Inc. Has $2.58 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

AMI Investment Management Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,905 shares of the healthcare conglomerate’s stock after selling 303 shares during the period. AMI Investment Management Inc.’s holdings in UnitedHealth Group were worth $2,582,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Values Added Financial LLC grew its position in shares of UnitedHealth Group by 18.1% during the 4th quarter. Values Added Financial LLC now owns 1,059 shares of the healthcare conglomerate’s stock valued at $558,000 after acquiring an additional 162 shares during the period. Strong Tower Advisory Services boosted its holdings in UnitedHealth Group by 0.7% in the 4th quarter. Strong Tower Advisory Services now owns 20,253 shares of the healthcare conglomerate’s stock worth $10,663,000 after buying an additional 131 shares during the period. Francis Financial Inc. boosted its holdings in UnitedHealth Group by 14.3% in the 4th quarter. Francis Financial Inc. now owns 455 shares of the healthcare conglomerate’s stock worth $240,000 after buying an additional 57 shares during the period. Ritholtz Wealth Management boosted its holdings in UnitedHealth Group by 19.4% in the 4th quarter. Ritholtz Wealth Management now owns 16,866 shares of the healthcare conglomerate’s stock valued at $8,880,000 after purchasing an additional 2,744 shares during the period. Finally, Accel Wealth Management bought a new position in UnitedHealth Group in the 4th quarter valued at $219,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Finally, Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Check Out Our Latest Analysis on UnitedHealth Group

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $494.70 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The stock has a market capitalization of $456.08 billion, a PE ratio of 20.75, a P/E/G ratio of 1.34 and a beta of 0.54. The company has a fifty day moving average of $503.10 and a two-hundred day moving average of $518.61. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.34 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.